This study, describing the analysis of snap-frozen samples of tumor and normal breast tissue for gene expression of the survivin protein, showed that five out of the five patients studied had luminal breast cancer tumors secreting survivin at significantly higher levels than adjacent normal tissue taken from the excision site. This evidence concerns the gene BIRC5 and breast cancer.